Compare ARK Genomic Revolution ETF (ARKG) vs BHP Billiton Limited (BHP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs BHP Billiton Limited — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while BHP Billiton Limited trades at $81.58 (market cap $204.10B). The key difference: BHP Billiton Limited pays a 3.26% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, BHP Billiton Limited nearer its low. Which is the better fit depends on your goals.
| ARKG | BHP | |
|---|---|---|
Sector | Sector/Thematic | Basic Materials |
52-Week High | $43.57 | $93.15 |
52-Week Low | $23.09 | $50.37 |
Market Cap | — | $204.10B |
Enterprise Value | — | $218.31B |
Dividend Yield | — | 3.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
BHP trades at $81.68, up 2.21% today, with a bearish technical signal from moving averages. The company reported Q4 2025 EPS of $2.24, missing the $2.41 estimate, but beat in Q2 2025. Recent news highlights a potential strike at Port Hedland threatening daily revenue and a $2.3 billion writedown at the Jansen potash project due to cost overruns. Revenue for 2024 was $55.66 billion with a net income margin of 18.97%, while the P/E ratio stands at 20.29.
The outlook is mixed; strong profitability and cash flow support value, but operational disruptions and project cost increases pose near-term risks. Analyst consensus is cautious with 64.52% hold ratings. Investors should weigh solid fundamentals against execution challenges and commodity price volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About BHP Billiton Limited
BHP Group Limited operates as a mining company. The Company engages in the exploration, development, production, and processing of iron ore, metallurgical coal, and copper. BHP Group serves customers worldwide.
Read more on BHP →
